CDC-RFA-DD-23-0002: Sickle Cell Data Collection Program
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCBDDD notices from 2023.
Centers for Disease Control - NCBDDD offered grants of up to $600,000 (at least $100,000) to any type of organization. It expected to make about 13 awards worth $25.0 million in total. Applications closed on May 11, 2023.
From the official notice on Grants.gov, last changed February 15, 2023. Checked November 7, 2026.
- Award ceiling$600,000
- Award floor$100,000
- Total funding$25.0 million
- Expected awards13
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 9, 2023 |
|---|---|
| Deadline | May 11, 2023 |
| Archived by Grants.gov | June 10, 2023 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Applicants may apply for Component A or Component B and indicate this in the first statement of their Project Narrative. If an applicant applies for both Components, their applications will be deemed non-responsive and neither will be reviewed.
Is this a realistic fit?
- Past Blood Disorder Program: Prevention, Surveillance, and Research awards averaged $1.1 million; this notice allows up to $600,000 per award.
- Most of the program's money (61% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
Sickle cell disease (SCD), estimated to affect 90,000 to 100,000 Americans, is the most common inherited blood disorder in the United States. Major complications of SCD include anemia, debilitating pain, infection, stroke, and organ damage. There is no national surveillance of SCD. Consequently, there are large gaps in our current understanding of the natural course of the disease and its variable manifestations from one patient to the next, including how vulnerable populations seek and receive SCD care. The intent of the Sickle Cell Data Collection (SCDC) program is to inform decisions and policies that may lead to significant improvements in the SCD community, a community that continues to be impacted by racism, bias, and prejudice. The efforts of the SCDC program have led to changes in health care policy and increased access to health care services for SCD at both the local and state level. SCDC data have informed the location of new SCD clinics, based on the number of people with SCD compared to the number of SCD health care specialists. They have also been used to identify people with SCD who are eligible for newly expanded Medicaid services. Additional examples of the translation of SCDC data into actions that improve and extend the lives of people with SCD, including actions reaching further than health care, alone, are expected as the program continues to expand. Through this Notice of Funding Opportunity (NOFO), CDC plans to fund recipients for a five-year period of performance to implement the SCDC program. All recipients will adhere to standardized methods for implementing SCDC, develop strategies for effective communication with stakeholders from the SCD community, and produce peer-reviewed publications and other educational materials based on SCDC findings. They will also establish or enhance their partner collaborations and explore paths by which the data may be used to inform policies beyond health care, such as those concerning transportation, education, housing, or employment, that impact individuals with SCD. There will be two components, component A (implementation and technical assistance) and component B (capacity building and implementation), with the expectation of a close, working one-on-one collaboration between each component B recipient and a component A recipient.
Who has won Blood Disorder Program: Prevention, Surveillance, and Research grants before
From fiscal 2021 to 2025, Blood Disorder Program: Prevention, Surveillance, and Research (93.080) awarded $39.7 million across 36 grant awards, an average of $1.1 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| American Thrombosis & Hemostasis Network Inc | New York | 1 | $12.9 million |
| The Jeffrey Modell Foundation, Inc. | New York | 1 | $6.0 million |
| Georgia State University Research Foundation Inc | Georgia | 3 | $2.5 million |
| Regents of the University of Michigan | Michigan | 2 | $1.8 million |
| Public Health Institute | California | 2 | $1.6 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-DD-23-0002 still open?
No. It closed on May 11, 2023.
Who can apply for Sickle Cell Data Collection Program?
Centers for Disease Control - NCBDDD accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Sickle Cell Data Collection Program?
Closed May 11, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $600,000 each. About $25.0 million in total across about 13 awards.
Who has won Blood Disorder Program: Prevention, Surveillance, and Research grants before?
The largest recipients over five fiscal years were American Thrombosis & Hemostasis Network Inc, The Jeffrey Modell Foundation, Inc., Georgia State University Research Foundation Inc. The program made 36 awards worth $39.7 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)